RENAL-FUNCTION NOT IMPAIRED BY HIP-ARTHROPLASTY - A PROSPECTIVE-STUDY OF 26 PATIENTS

被引:7
|
作者
STEGMAYR, BG
BJORCK, L
KEMPI, V
SEMB, H
机构
[1] CTY HOSP,DEPT RADIOPHYS,OSTERSUND,SWEDEN
[2] CTY HOSP,DEPT ORTHOPED,OSTERSUND,SWEDEN
来源
ACTA ORTHOPAEDICA SCANDINAVICA | 1992年 / 63卷 / 01期
关键词
D O I
10.3109/17453679209154840
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
To evaluate the importance of various changes during major surgery, 26 patients, electively chosen for total hip replacement (THR), were investigated for renal function preoperatively and postoperatively. In most of the patients, surgery was performed ad modum Charnley (n 25), and anesthesia was given mainly by continuous administration of bupivacaine or mepivacaine through an epidural catheter. Postoperatively, there was an improvement in glomerular filtration rate (GFR) and a reduction in renal concentrating ability (RCA), but no change in diurnal albumin excretion. No correlation was found between the change in GFR and, e.g., the degree of peroperative hypotension, bleeding, transfusions, or volume of infusions. There was a correlation between the impairment of RCA and the lowering of serum albumin concentration. In 3 patients the GFR was slightly impaired. The risk of contracting severe, acute renal failure seems low in THR performed on patients with reduced or normal kidney function.
引用
收藏
页码:7 / 12
页数:6
相关论文
共 50 条
  • [31] STUDIES WITH ALLOPURINOL IN PATIENTS WITH IMPAIRED RENAL-FUNCTION
    ELION, GB
    BENEZRA, FM
    BEARDMORE, TD
    KELLEY, WN
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1979, 17 (06): : 405 - 405
  • [32] PHARMACOKINETICS OF TENOXICAM IN PATIENTS WITH IMPAIRED RENAL-FUNCTION
    HORBER, FF
    GUENTERT, TW
    WEIDEKAMM, E
    HEIZMANN, P
    DESCOEUDRES, C
    FREY, FJ
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 29 (06) : 697 - 701
  • [33] PHARMACOKINETICS OF RUFLOXACIN IN PATIENTS WITH IMPAIRED RENAL-FUNCTION
    PERRY, G
    MANT, TGK
    MORRISON, PJ
    SACKS, S
    WOODCOOK, J
    WISE, R
    IMBIMBO, BP
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (04) : 637 - 641
  • [34] FENOLDOPAM, BUT NOT NITROPRUSSIDE, IMPROVES RENAL-FUNCTION IN SEVERELY HYPERTENSIVE PATIENTS WITH IMPAIRED RENAL-FUNCTION
    SHUSTERMAN, NH
    ELLIOTT, WJ
    WHITE, WB
    AMERICAN JOURNAL OF MEDICINE, 1993, 95 (02): : 161 - 168
  • [35] PHARMACOKINETICS OF CEFADROXIL IN PATIENTS WITH IMPAIRED RENAL-FUNCTION
    LEROY, A
    HUMBERT, G
    GODIN, M
    FILLASTRE, JP
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1982, 10 : 39 - 46
  • [36] ELIMINATION OF ISONIAZID IN PATIENTS WITH IMPAIRED RENAL-FUNCTION
    REIDENBE.MM
    SHEAR, L
    COHEN, RV
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1973, 108 (06): : 1426 - 1428
  • [37] PHARMACOKINETICS OF AMIKACIN IN PATIENTS WITH IMPAIRED RENAL-FUNCTION
    MCHENRY, MC
    WAGNER, JG
    HALL, PM
    VIDT, DG
    GAVAN, TL
    JOURNAL OF INFECTIOUS DISEASES, 1976, 134 : S343 - S348
  • [38] DRUG KINETICS IN PATIENTS WITH IMPAIRED RENAL-FUNCTION
    WALTERS, L
    SOUTH AFRICAN MEDICAL JOURNAL, 1982, 61 (19): : 705 - 707
  • [39] PARENTERAL FEEDING IN PATIENTS WITH IMPAIRED RENAL-FUNCTION
    CAPARROS, T
    LOPEZMARTINEZ, J
    PEREZPICOUTO, F
    RUIZOCANA, F
    FERNANDEZFERNANDEZ, A
    REVISTA CLINICA ESPANOLA, 1977, 144 (06): : 433 - 438
  • [40] PHARMACOKINETICS OF CINOXACIN IN PATIENTS WITH IMPAIRED RENAL-FUNCTION
    OHKAWA, M
    SUGATA, T
    SAWAKI, M
    OKASHO, A
    KAWAGUCHI, K
    TAKANO, M
    KURODA, K
    CHEMOTHERAPY-TOKYO, 1980, 28 : 133 - 138